Last update 23 Jan 2025

Tonghua Tongbo Biomedical Co., Ltd.

Company|
2010|
Jilin Sheng, China
|
< 10

Overview

Related

1
Drugs associated with Tonghua Tongbo Biomedical Co., Ltd.
Liraglutide Biosimilar (Tonghua Dongbao)
Target
GLP-1R
Mechanism
GLP-1R agonists
Active Org.
Tonghua Dongbao Pharmaceutical Co., Ltd.Tonghua Dongbao Pharmaceutical Co., Ltd.
Originator Org.
Tonghua Dongbao Pharmaceutical Co., Ltd.Tonghua Dongbao Pharmaceutical Co., Ltd.
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date28 Nov 2023
2
Clinical Trials associated with Tonghua Tongbo Biomedical Co., Ltd.
CTR20190885
/ CompletedPhase 1
随机、双盲、单剂量、2x2交叉研究，以证明通化东宝利拉鲁肽注射液和诺和力在健康受试者中生物等效性试验
[Translation] A randomized, double-blind, single-dose, 2x2 crossover study to demonstrate the bioequivalence of Tonghua Dongbao Liraglutide Injection and Victoza in healthy subjects
CTR20190791
/ CompletedPhase 3
II期多中心随机开放标签平行组为期26周，比较利拉鲁肽注射液和诺和力在2型糖尿病中的疗效和安全性
[Translation] Phase II multicenter randomized open-label parallel group for 26 weeks to compare the efficacy and safety of liraglutide injection and Victoza in type 2 diabetes
100 Clinical Results associated with Tonghua Tongbo Biomedical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Tonghua Tongbo Biomedical Co., Ltd.
Login to view more data
100 Deals associated with Tonghua Tongbo Biomedical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Tonghua Tongbo Biomedical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 28 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Liraglutide Biosimilar (Tonghua Dongbao)
 ( GLP-1R )		Diabetes Mellitus, Type 2
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free